GIST

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Familial Investigations of Childhood Cancer Predisposition

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting

RCT of EFTR Versus STER for GIST Treatment

A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib

SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST

Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients

TARGETed Therapy Drug MONITOring in DIGestive Oncology

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

A Study of Olverembatinib in SDH-deficient GIST.

A Drug-drug Interaction Study of Avapritinib and Midazolam

Temozolomide (TMZ) in Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)

Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)

French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients

Detective Flow Imaging Endoscopic Ultrasonography in Subepithelial Lesions

Vaccine Therapy in Treating Patients With Metastatic Solid Tumors

Exploring the Molecular Mechanism Based on KIT Mutation

Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors